SCALP MICRONEEDLING MARKET ANALYSIS

Scalp Microneedling is a process that causes minor superficial injury to the scalp that stimulates hair follicles and thus promotes new hair growth, and increases the blood circulation in the scalp. It also helps in increased collagen synthesis. Microneedling also helps in absorption of products deep into the scalp. It is done with a dermaroller or dermapen, they come in different sizes. The choice of the depth of microneedling depends on the scalp condition of every patient. These microneedling devices consist of very fine multiple titanium needles that are completely safe for the skin and don't cause any damage to the skin.

The global scalp microneedling market is estimated to be valued at US$ 179.5 million in 2022 and expected to increase to US$ 336.3 million by 2030, witnessing a CAGR of 8.2% over the forecast period (2022-2030).

Figure 1. Global Scalp Microneedling Market Share (%), By Region, 2022

To learn more about this report, request a free sample copy

The rising prevalence of hair loss disorders is expected to drive the growth of the global scalp microneedling market.

Alopecia areata is a type of autoimmune disorder that causes hair loss, often in clumps, the size and shape of a quarter. The amount of hair loss is different in everyone. Some people lose it only in a few spots. Therefore, increasing prevalence of hair loss will surge the demand for scalp microneedling devices, and is expected to drive the market growth over the forecast period.

For instance, according to a study published by Journal of Family Medicine and Primary Care, in October 2021, to evaluate the prevalence of hair loss and its associated risk factors among primary healthcare centre (PHC) attendance in the Jazan region in southwest Saudi Arabia, near the northern border of Yemen, a cross-sectional study was done. The data was obtained in a number of PHCs around the region during August and October 2020. A total of 729 people agreed to participate in this study. There were 483 respondents who said they had hair loss, accounting for 66.3 percent of the total sample. The most variable factor appears to be gender, with the majority of participants reporting hair loss being female (P < 0.001). Telogen effluvium was the most common kind of hair loss, followed by androgenic alopecia.

Figure 2. Global Scalp Microneedling Market Share (%) Analysis, By Product Type, 2022

To learn more about this report, request a free sample copy

High cases of chemotherapy-induced hair loss is expected to drive the growth of the global scalp microneedling market.

As stated by BioMed Central Ltd., a part of Springer Nature, in December 2019, chemotherapy is a major type of cancer treatment using chemical medications to affect cancer cell growth, division and reproduction. Hair loss is a major side effect of chemotherapy. According to the same source, the incidence of chemotherapy-induced hair loss is as high as 65% in patients receiving chemotherapy and in some is even up to 80–100% in patients receiving specific agents, such as doxorubicin and docetaxel.

Global Scalp Microneedling Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 outbreak in December 2019, the disease has spread to over 100 countries across the globe. The coronavirus (COVID 19) pandemic and consequent lockdown in various countries across the globe have impacted the financial status of businesses in all sectors. The coronavirus pandemic has also hindered the development, production, and supply of medical devices and other healthcare products and affected the growth of the healthcare business of many companies around the world.

Many dermatology clinics and services were halted due to their elective nature and severely affected the operations of many aesthetic clinics due to the reduced patient footfall. However, many dermatologists believe that COVID-19 may act as a springboard that will drastically increase patient footfall post-pandemic. For instance, according to the American Society of Plastic Surgeons, in 2020, the pandemic led to an increase in the acceptance of cosmetic procedures. The 2020 association’s survey of more than 1,000 women in the U.S. reported that 11% of the women are now more inclined and interested in nonsurgical procedures than before COVID-19.

Global Scalp Microneedling Market: Restraint

Possible side effects associated with scalp microneedling include bruising, oozing from the wounds, redness, swelling, and pain, which are expected to hamper the global scalp microneedling market growth. There’s also a risk that the wounds caused by the needles may form scar.

Key Players

Major players operating in the global scalp microneedling market include Dermapen, Dermaroller GmbH, Zcalp, Envision Medical Spa, MDPen Fractional Microdermal Needling, DermaConcepts, ConceptSkincare, Ramboll Environ, Inc., Edge Systems LLC., Weyergans High Care, and Bomtech Electronics Co., Ltd.